CSC Plasticity and Tumor Progression

Cancer stem cells (CSCs) exhibit remarkable plasticity, allowing them to switch between stem-like and differentiated states in response to microenvironmental cues. This track explores the mechanisms underlying CSC plasticity and how it contributes to tumor progression, metastasis, and therapeutic resistance. Researchers study the factors that regulate transitions between CSC and non-CSC states, including epigenetic changes and signaling pathways. Targeting CSC plasticity could prevent tumors from adapting to therapies and evolving into more aggressive forms. By understanding how plasticity drives tumor heterogeneity and survival, researchers aim to develop therapies that eliminate CSCs and block tumor progression, reducing the chances of relapse.

    Related Conference of CSC Plasticity and Tumor Progression

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    CSC Plasticity and Tumor Progression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in